All news

FLSC SEC Filings - Frazier Life Sciences Acquisition Corp. II 10-K, 10-Q, 8-K Forms

Alpha Vantage · Stock Titan · · AI-summarised by FinFlash

This article provides an overview of recent SEC filings for Frazier Life Sciences Acquisition Corp. II (FLSC), a biotechnology-focused SPAC. Key filings include details about its IPO offering, including the number of shares, pricing, and the absence of warrants for investors, as well as insider holdings of Class B shares by its CFO, directors, and sponsor.

Read original source

FLSC company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.